万孚生物(300482.SZ)第三季度净亏损5545.91万元

Core Viewpoint - Wanfu Biological (300482.SZ) reported a significant decline in revenue and net profit for the third quarter of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved a revenue of 445 million yuan in the third quarter, a year-on-year decrease of 26.66% [1] - For the first three quarters, the total revenue was 1.69 billion yuan, reflecting a year-on-year decline of 22.52% [1] - The net loss for the third quarter amounted to 55.46 million yuan [1] - The net profit for the first three quarters was 134 million yuan, which represents a year-on-year decrease of 69.32% [1]